Enanta Pharmaceuticals (ENTA) Market Capitalization (2013 - 2026)
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Market Capitalization (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Enanta Pharmaceuticals | 409.30 Mn | 219.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 424.57 Mn |
| Mar 31, 2026 | 367.04 Mn |
| Dec 31, 2025 | 457.63 Mn |
| Sep 30, 2025 | 256.00 Mn |
| Jun 30, 2025 | 161.62 Mn |
| Mar 31, 2025 | 118.00 Mn |
| Dec 31, 2024 | 122.66 Mn |
| Sep 30, 2024 | 219.57 Mn |
| Jun 30, 2024 | 274.73 Mn |
| Mar 31, 2024 | 369.79 Mn |
| Dec 31, 2023 | 199.08 Mn |
| Sep 30, 2023 | 235.23 Mn |
| Jun 30, 2023 | 450.60 Mn |
| Mar 31, 2023 | 851.22 Mn |
| Dec 31, 2022 | 971.52 Mn |
| Sep 30, 2022 | 1.08 Bn |
| Jun 30, 2022 | 979.43 Mn |
| Mar 31, 2022 | 1.47 Bn |
| Dec 31, 2021 | 1.53 Bn |
| Sep 30, 2021 | 1.15 Bn |